172900-88-8

Basic information

• Product Name: 5-Oxazolidinepropanoic acid, 3-[(1,1-diMethylethoxy)carbonyl]-4-[(2S)-2-[[4-Methoxy-3-(3-Methoxypropoxy)phenyl]Methyl]-3-Methylbutyl]-2,2-diMethyl-α-(1-Methylethyl)-, (αS,4S,5S)-
• Synonyms: 5-Oxazolidinepropanoic acid, 3-[(1,1-diMethylethoxy)carbonyl]-4-[(2S)-2-[[4-Methoxy-3-(3-Methoxypropoxy)phenyl]Methyl]-3-Methylbutyl]-2,2-diMethyl-α-(1-Methylethyl)-, (αS,4S,5S)-;5-Oxazolidinepropanoic acid, 3-[(1,1-diMethylethoxy)carbonyl]-4-[(2S)-2-[[4-Methoxy-3-(3-Methoxyprop
• CAS NO: 172900-88-8
• Molecular Formula: C₃₃H₅₅NO₈
• Molecular Weight: 593.79200
• Mol File: 172900-88-8.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 5-Oxazolidinepropanoic acid, 3-[(1,1-diMethylethoxy)carbonyl]-4-[(2S)-2-[[4-Methoxy-3-(3-Methoxypropoxy)phenyl]Methyl]-3-Methylbutyl]-2,2-diMethyl-α-(1-Methylethyl)-, (αS,4S,5S)-(CAS DataBase Reference)
• NIST Chemistry Reference: 5-Oxazolidinepropanoic acid, 3-[(1,1-diMethylethoxy)carbonyl]-4-[(2S)-2-[[4-Methoxy-3-(3-Methoxypropoxy)phenyl]Methyl]-3-Methylbutyl]-2,2-diMethyl-α-(1-Methylethyl)-, (αS,4S,5S)-(172900-88-8)
• EPA Substance Registry System: 5-Oxazolidinepropanoic acid, 3-[(1,1-diMethylethoxy)carbonyl]-4-[(2S)-2-[[4-Methoxy-3-(3-Methoxypropoxy)phenyl]Methyl]-3-Methylbutyl]-2,2-diMethyl-α-(1-Methylethyl)-, (αS,4S,5S)-(172900-88-8)

Safety Data

• Hazardous Substances Data: 172900-88-8(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
5-Oxazolidinepropanoic acid, 3-[(1,1-dimethylethoxy)carbonyl]-4-[(2S)-2-[[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl]-3-methylbutyl]-2,2-dimethyl-α-(1-methylethyl)-, (αS,4S,5S)is used as a pharmaceutical intermediate for the synthesis of various drugs and medications. Its unique structure and functional groups make it a valuable building block in the development of new pharmaceutical compounds.
Used in Chemical Research:
5-Oxazolidinepropanoic acid, 3-[(1,1-diMethylethoxy)carbonyl]-4-[(2S)-2-[[4-Methoxy-3-(3-Methoxypropoxy)phenyl]Methyl]-3-Methylbutyl]-2,2-diMethyl-α-(1-Methylethyl)-, (αS,4S,5S)is also used in chemical research for studying the properties and reactions of complex organic molecules. Its unique structure and functional groups provide valuable insights into the behavior of similar compounds and contribute to the advancement of organic chemistry.
Used in Material Science:
5-Oxazolidinepropanoic acid, 3-[(1,1-dimethylethoxy)carbonyl]-4-[(2S)-2-[[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl]-3-methylbutyl]-2,2-dimethyl-α-(1-methylethyl)-, (αS,4S,5S)can be used in the development of new materials with specific properties. Its unique structure and functional groups can be utilized to create materials with tailored characteristics for various applications in industries such as plastics, coatings, and adhesives.

Upstream product

• 172900-89-9 (4S,5S,2'S,2''S)-5-(2'-formyl-3-methylbutyl)-4-{2''-[4-methoxy-3-(3-methoxypropoxy)benzyl]-3-methylbutyl}-2,2-dimethyloxazolidine-3-carboxylic acid tert-butyl ester 
• 172900-90-2 (4S,5S,2'S,2''S)-5-(2'-hydroxymethyl-3-methylbutyl)-4-{2''-[4-methoxy-3-(3-methoxypropoxy)benzyl]-3-methylbutyl}-2,2-dimethyloxazolidine-3-carboxylic acid tert-butyl ester 

Downstream Products

• 173336-46-4 3-tert-butoxycarbonyl-5(S)-{2(S)-[N-(1-carbamoyl-1-methyl-ethyl)-carbamoyl]-2(S)-isopropyl-ethyl}-4(S)-{2(S)-isopropyl-3-[4-methoxy-3-(3-methoxypropyloxy)-phenyl]-propyl}-2,2-dimethyl-1,3-oxazolidine 
• 172900-87-7 3-tert-butoxycarbonyl-5(S)-{2(S)-[N-(2-morpholino-ethyl)-carbamoyl]-2(S)-isopropyl-ethyl}-4(S)-{2(S)-isopropyl-3-[4-methoxy-3-(3-methoxypropyloxy)-phenyl]-propyl}-2, 2-dimethyl-1,3-oxazolidine 

Relevant articles and documents

Structural modification of the P2′ position of 2,7-dialkyl- substituted 5(S)-amino-4(S)-hydroxy-8-phenyl-octanecarboxamides: The discovery of aliskiren, a potent nonpeptide human renin inhibitor active after once daily dosing in marmosets

Due to its function in the rate limiting initial step of the renin-angiotensin system, renin is a particularly promising target for drugs designed to control hypertension, a growing risk to health worldwide. Despite vast efforts over more than two decades

METHODS OF TREATING ALZHEIMER'S DISEASE USING ARYL ALKANOIC ACID AMIDES

Disclosed are methods for treating Alzheimer’s disease, and other diseases, and/or inhibiting beta-secretase enzyme, and/or inhibiting deposition of A beta peptide in a mammal, by use of compounds of formula 1 (1) wherein the variables R1-R8 and X are defined herein.